Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Harvard Med School Building Biomedical Research Facility
Harvard Medical School broke ground in February 2001 on a new $250 million collaborative biomedical research facility designed by Architectural Resources Cambridge. The 430,000-gsf facility will be shared by Harvard Medical School basic science departments and collaborative tenants from Harvard’s affiliate institutions. To enhance interdisciplinary research, the facility has been designed with faculty members doing related work in adjacent labs and sharing core facilities.
UConn Dedicates New Marine Sciences Facility
The University of Connecticut’s ocean-front Avery Point campus on Long Island Sound recently dedicated the University’s new Marine Sciences building. The 140,000-sf structure, designed by The S/L/A/M Collaborative of Glastonbury, Conn., contains research and teaching labs (including four “clean” chemistry labs), support facilities, offices, conference and seminar spaces, saltwater fluid dynamics labs, computer labs, and classrooms.
Maryland Science/Tech Center Nears Phase I Completion
Maryland Science and Technology Center, a $60 million, 14-building complex, expects to complete Phase I of construction—a total of 120,000 sf of space in one office building and two flex and R&D buildings—by February 2002. The buildings were designed by Robert T. Hoffman. Phase II construction will create four flex and R&D facilities. MEI Properties is the developer of the project at the 466-acre office park.
Dow Chemical Plans Biotech Contract Manufacturing Plant
Dow Chemical Co., based in Midland, Mich., is planning to transform a 55,000-sf facility previously occupied by Collaborative Group Ltd.’s Biotechnology Services Division into a large-molecule drugs contract manufacturing plant to serve the biotech industry. The facility will have a 50,000-liter capacity. World-wide, the capacity to produce large-molecule drugs stands at about 380,000 liters, with a critical shortage of capacity anticipated by 2005.
Charles River Labs Builds Transgenic Facility
Charles River Laboratories International, a provider of contract services and research animals to the biotech and pharmaceutical industries, has a 68,000-sf transgenic facility under construction at their Wilmington headquarters. Completion of the building is anticipated in spring 2002. Demand for the company’s products increased significantly as the mapping of the human genome revealed genetic similarities between mice and humans.